The Division of Hematology Oncology at the University of Massachusetts Medical School offers comprehensive evaluation and treatment of blood disorders (Hematology) and cancer (Oncology). Division faculty members work closely with colleagues in surgical oncology, radiation oncology, pathology, and radiology. This collection showcases journal articles and other publications authored by faculty and researchers of the Division of Hematology Oncology.

Follow


Publications from 1994

Link

Issues in breast cancer screening in older women, Mary E. Costanza

Link

The extent of breast cancer screening in older women, Mary E. Costanza

Publications from 1993

Link

Molecular basis for heme-dependent induction of heme oxygenase in primary cultures of chick embryo hepatocytes. Demonstration of acquired refractoriness to heme, Kishore K. Srivastava, Edward Earl Cable, Susan E. Donohue, and Herbert L. Bonkovsky

Link

Impact of a breast cancer screening community intervention, Jane G. Zapka, Mary E. Costanza, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women, Jane G. Zapka, Donald R. Harris, David W. Hosmer, Mary E. Costanza, Edith Mas, and Robin S. Barth

Publications from 1992

Link

Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh), Herbert L. Bonkovsky, Edward Earl Cable, Julia W. Cable, Susan E. Donohue, Emily C. White, Yvonne J. Greene, Richard W. Lambrecht, Kishore K. Srivastava, and Wilfred N. Arnold

PDF

The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study, Doreen B. Brettler, Pier Mannuccio Mannucci, Alessandro Gringeri, John E. J. Rasko, Ann D. Forsberg, Maria Grazia Rumi, Roger J. Garsia, Kathleen A. Rickard, and Massimo Colombo

PDF

Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population, Doreen B. Brettler, Mohan Somasundaran, A. F. Forsberg, E. Krause, and John L. Sullivan

Link

Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium, E. A. Coleman, E. J. Feuer, and Mary E. Costanza

Link

Breast cancer screening in older women. Synopsis of a forum, Mary E. Costanza

Link

Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Mary E. Costanza

Link

Phase II studies: untreated breast cancer patients, Mary E. Costanza

Link

Physician compliance with mammography guidelines: barriers and enhancers, Mary E. Costanza, Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth

PDF

Impact of a physician intervention program to increase breast cancer screening, Mary E. Costanza, Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard

Link

Guidelines for breast cancer screening, Stephanie Shapiro, C. R. Smart, Mary E. Costanza, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz

Link

Emphasizing screening activities in a community health center: a case study of a breast cancer screening project, Jane G. Zapka, L. Chasan, Robin S. Barth, Edith Mas, and Mary E. Costanza

PDF

Changes in mammography use: economic, need, and service factors, Jane G. Zapka, David W. Hosmer, Mary E. Costanza, Donald R. Harris, and Anne M. Stoddard

Publications from 1991

Link

Screening mammography, Mary E. Costanza

Link

Feasibility of universal screening mammography. Lessons from a community intervention, Mary E. Costanza, C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka

Link

Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study, N. A. Dawson, Mary E. Costanza, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton

Link

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities, Richard A. Koup, Cheryl A. Pikora, Katherine Luzuriaga, Doreen B. Brettler, Eric S. Day, Gail Mazzara, and John L. Sullivan

Link

Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children, Katherine Luzuriaga, Richard A. Koup, Cheryl A. Pikora, Doreen B. Brettler, and John L. Sullivan

Link

Validity and reliability of psychosocial factors related to breast cancer screening, Jane G. Zapka, D. R. Harris, Anne M. Stoddard, and Mary E. Costanza

Link

Interval adherence to mammography screening guidelines, Jane G. Zapka, Anne M. Stoddard, L. Maul, and Mary E. Costanza

Publications from 1990

Link

Screening mammography: a missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies

PDF

Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients, Doreen B. Brettler, Harvey J. Alter, Jules L. Dienstag, Ann D. Forsberg, and Peter H. Levine

Link

Hypersensitivity reactions to trimetrexate, J. L. Grem, S. A. King, Mary E. Costanza, and T. D. Brown

Link

Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study, H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, Mary E. Costanza, and Michael R. Green

Publications from 1989

PDF

Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies, Doreen B. Brettler, Ann D. Forsberg, Peter H. Levine, J. Petillo, K. Lamon, and John L. Sullivan

PDF

Factor concentrates for treatment of hemophilia: which one to choose, Doreen B. Brettler and Peter H. Levine

PDF

Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs, Richard A. Koup, John L. Sullivan, Peter H. Levine, Doreen B. Brettler, Anna Mahr, Gail Mazzara, Sara McKenzie, and Dennis Panicali

PDF

Breast cancer screening by mammography: utilization and associated factors, Jane G. Zapka, Anne M. Stoddard, Mary E. Costanza, and Harru L. Greene Jr.

Publications from 1988

Link

5-Fluorouracil-associated cardiotoxicity, N. J. Freeman and Mary E. Costanza

Publications from 1986

Link

Increasing the effort toward breast cancer detection, Michael D. Wertheimer, Mary E. Costanza, T. F. Dodson, Carl J. D'Orsi, Harris Pastides, and Jane G. Zapka

Publications from 1984

Link

Predictive testing with the subrenal capsule assay, A. E. Bogden, W. Griffin, S. D. Reich, Mary E. Costanza, and W. R. Cobb

Link

Adjuvant chemotherapy. Eight years later, Mary E. Costanza

Publications from 1983

Link

Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update, A. E. Bogden, Mary E. Costanza, S. D. Reich, T. W. Griffin, and W. R. Cobb

Link

Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy, T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, H. L. Greene Jr., and Mary E. Costanza

Link

Effects on metastases of drug therapy during developing and established tumor immunity, J. Vaage and Mary E. Costanza

Publications from 1982

Link

The medical management of breast cancer, Mary E. Costanza

Publications from 1979

Link

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa, Mary E. Costanza, M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma, J. Vaage and Mary E. Costanza

Publications from 1977

Link

Results with methyl-CCNU and DTIC in metastatic melanoma, Mary E. Costanza, L. Nathanson, David A. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, Timothy Cunningham, and N. Sedransk

Link

Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary, Won K. Tak, Mary E. Costanza, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami

Publications from 1976

Link

Letter: Chemotherapy of breast cancer, Mary E. Costanza

Link

Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma, Mary E. Costanza, L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson

Link

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses, R. F. Gagel, Mary E. Costanza, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson

Link

Familial colon cancer, M. S. Miller, Mary E. Costanza, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson

Publications from 1975

Link

Sounding Board. The problem of breast-cancer prophylaxis, Mary E. Costanza

Publications from 1974

Link

Proceedings: Carcinoembryonic antigen. Report of a screening study, Mary E. Costanza, S. Das, L. Nathanson, A. Rule, and R. S. Schwartz

Link

Metastatic basal cell carcinoma: review, report of a case, and chemotherapy, Mary E. Costanza, Y. Dayal, S. Binder, and L. Nathanson

Link

Carcinofetal antigens, Mary E. Costanza and L. Nathanson

Publications from 1973

Link

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome, Mary E. Costanza, V. Pinn, R. S. Schwartz, and L. Nathanson

Publications from 1972

Link

Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea, Mary E. Costanza, L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling

Link

Munchausen syndrome--further follow-up, M. J. Lynch, M. Kasakian, and Mary E. Costanza

Publications from 1968

Link

The vulnerable children revisted. A follow-up study of children three to six years after acute illness in infancy, Mary E. Costanza, I. Lipsitch, and E. Charney